Serum Irisin Levels, Endothelial Dysfunction, and Inflammation in Pediatric Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome

Trends in Incidence of Type 1 and Type 2 Diabetes Among Youths — Selected Counties and Indian Reservations, United States, 2002–2015

(2020) Jasmin Divers et al.   MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT

HDL and cardiovascular disease

(2019) Stephen J. Nicholls et al.   PATHOLOGY

Association between Irisin, hs-CRP, and Metabolic Status in Children and Adolescents with Type 2 Diabetes Mellitus

(2019) Leticia Elizondo-Montemayor et al.   MEDIATORS OF INFLAMMATION

FNDC5/Irisin inhibits pathological cardiac hypertrophy

(2019) Qing Yu et al.   CLINICAL SCIENCE

IL-18, VCAM-1 and P-selectin as early biomarkers in normoalbuminuric Type 2 diabetes patients

(2019) Khalid Al-Rubeaan et al.   Biomarkers in Medicine

Serum E-selectin concentration is associated with risk of metabolic syndrome in females

(2019) Chien-Hsing Lee et al.   PLoS One

Myokine–adipokine cross-talk: potential mechanisms for the association between plasma irisin and adipokines and cardiometabolic risk factors in Mexican children with obesity and the metabolic syndrome

(2019) Adrian M. Gonzalez-Gil et al.   Diabetology & Metabolic Syndrome

Atherosclerosis

(2019) Peter Libby et al.   Nature Reviews Disease Primers

Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents

(2019) Chunyan Yin et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

The immunomodulatory role of irisin on osteogenesis via AMPK-mediated macrophage polarization

(2019) Wenbin Ye et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Macrophage plasticity, polarization, and function in health and disease

(2018) Abbas Shapouri-Moghaddam et al.   JOURNAL OF CELLULAR PHYSIOLOGY

High irisin levels in overweight/obese children and its positive correlation with metabolic profile, blood pressure, and endothelial progenitor cells

(2018) F. De Meneck et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Irisin protects macrophages from oxidized low density lipoprotein-induced apoptosis by inhibiting the endoplasmic reticulum stress pathway

(2018) Guanlin Zheng et al.   SAUDI JOURNAL OF BIOLOGICAL SCIENCES

Inflammation Markers in Type 2 Diabetes and the Metabolic Syndrome in the Pediatric Population

(2018) Thomas Reinehr et al.   Current Diabetes Reports

Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association

(2018) Silva Arslanian et al.   DIABETES CARE

Relationship of Circulating Irisin with Body Composition, Physical Activity, and Cardiovascular and Metabolic Disorders in the Pediatric Population

(2018) Leticia Elizondo-Montemayor et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The potential of irisin as a therapeutic for diabetes

(2017) Po Sing Leung   Future Medicinal Chemistry

Anti-Inflammatory Properties of Irisin, Mediator of Physical Activity, Are Connected with TLR4/MyD88 Signaling Pathway Activation

(2017) Agnieszka Irena Mazur-Bialy et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents

(2017) Han Byul Jang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Physiology and role of irisin in glucose homeostasis

(2017) Nikolaos Perakakis et al.   Nature Reviews Endocrinology

Adapting to obesity with adipose tissue inflammation

(2017) Shannon M. Reilly et al.   Nature Reviews Endocrinology

Markers of subclinical atherosclerosis in schoolchildren with obesity and metabolic syndrome

(2017)   SWISS MEDICAL WEEKLY

Association of Irisin Plasma Levels with Anthropometric Parameters in Children with Underweight, Normal Weight, Overweight, and Obesity

(2017) Leticia Elizondo-Montemayor et al.   Biomed Research International

The AGE-RAGE Axis: Implications for Age-Associated Arterial Diseases

(2017) Laura M. Senatus et al.   Frontiers in Genetics

Complex heatmaps reveal patterns and correlations in multidimensional genomic data

(2016) Zuguang Gu et al.   BIOINFORMATICS

The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype

(2016) You-Cheol Hwang et al.   Cardiovascular Diabetology

Irisin Increased the Number and Improved the Function of Endothelial Progenitor Cells in Diabetes Mellitus Mice

(2016) Guangxu Zhu et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Post-transcriptional down regulation of ICAM-1 in feto-placental endothelium in GDM

(2016) Francisca Isidora Díaz-Pérez et al.   Cell Adhesion & Migration

Irisin Lowers Blood Pressure by Improvement of Endothelial Dysfunction via AMPK‐Akt‐eNOS‐NO Pathway in the Spontaneously Hypertensive Rat

(2016) Jinjuan Fu et al.   Journal of the American Heart Association

Subclinical Inflammation and Endothelial Dysfunction in Young Patients with Diabetes: A Study from United Arab Emirates

(2016) Elhadi H. Aburawi et al.   PLoS One

Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway

(2015) Fang Han et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice

(2015) Junyan Lu et al.   ATHEROSCLEROSIS

New role of irisin in hepatocytes: The protective effect of hepatic steatosis in vitro

(2015) Min-Jung Park et al.   CELLULAR SIGNALLING

Irisin levels in the progression of diabetes in sedentary women

(2015) Iffet Dağdelen Duran et al.   CLINICAL BIOCHEMISTRY

Noncoding RNAs, cytokines, and inflammation-related diseases

(2015) José Luiz Marques-Rocha et al.   FASEB JOURNAL

Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues

(2015) J Dong et al.   INTERNATIONAL JOURNAL OF OBESITY

Endothelial microparticles reduce ICAM-1 expression in a microRNA-222-dependent mechanism

(2015) Felix Jansen et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Irisin and Its Relation to Insulin Resistance and Puberty in Obese Children: A Longitudinal Analysis

(2015) Thomas Reinehr et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses

(2015) Di Zhu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Irisin, a Novel Myokine, Regulates Glucose Uptake in Skeletal Muscle Cells via AMPK

(2015) Hye Jeong Lee et al.   MOLECULAR ENDOCRINOLOGY

Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway

(2015) Xian Jin et al.   Biomed Research International

Fibronectin type III domain containing 5 expression in skeletal muscle in chronic heart failure-relevance of inflammatory cytokines

(2015) Yae Matsuo et al.   Journal of Cachexia Sarcopenia and Muscle

Type 2 diabetes mellitus

(2015) Ralph A. DeFronzo et al.   Nature Reviews Disease Primers

Characterization of the metabolic effects of irisin on skeletal musclein vitro

(2014) R. A. Vaughan et al.   DIABETES OBESITY & METABOLISM

Association of Serum Irisin with Metabolic Syndrome in Obese Chinese Adults

(2014) Bing Yan et al.   PLoS One

Reactive Oxygen Species in Inflammation and Tissue Injury

(2013) Manish Mittal et al.   ANTIOXIDANTS & REDOX SIGNALING

Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

(2013) Kyung Hee Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of obesity, diabetes and exercise onFndc5gene expression and irisin release in human skeletal muscle and adipose tissue:in vivoandin vitrostudies

(2013) Timea Kurdiova et al.   JOURNAL OF PHYSIOLOGY-LONDON

Inflammation and type 2 diabetes

(2012) M.C. Calle et al.   DIABETES & METABOLISM

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

Utility of Hemoglobin A1c for Diagnosing Prediabetes and Diabetes in Obese Children and Adolescents

(2011) P. Nowicka et al.   DIABETES CARE

Regulation of effector and memory T-cell functions by type I interferon

(2011) Jonathan P. Huber et al.   IMMUNOLOGY

The role of interleukin-18 in the metabolic syndrome

(2010) Marius Trøseid et al.   Cardiovascular Diabetology

The p65 subunit of NF-κB binds to PGC-1α, linking inflammation and metabolic disturbances in cardiac cells

(2010) David Álvarez-Guardia et al.   CARDIOVASCULAR RESEARCH

Endothelial Dysfunction, Inflammation, and Apoptosis in Diabetes Mellitus

(2010) Inge A. M. van den Oever et al.   MEDIATORS OF INFLAMMATION

Intermittent High Glucose Stimulate MCP-l, IL-18, and PAI-1, but Inhibit Adiponectin Expression and Secretion in Adipocytes Dependent of ROS

(2009) Jiazhong Sun et al.   CELL BIOCHEMISTRY AND BIOPHYSICS

Subjects With Early-Onset Type 2 Diabetes Show Defective Activation of the Skeletal Muscle PGC-1 /Mitofusin-2 Regulatory Pathway in Response to Physical Activity

(2009) M. I. Hernandez-Alvarez et al.   DIABETES CARE

Cutting Edge: TNF-Induced MicroRNAs Regulate TNF-Induced Expression of E-Selectin and Intercellular Adhesion Molecule-1 on Human Endothelial Cells: Feedback Control of Inflammation

(2009) Yajaira Suárez et al.   JOURNAL OF IMMUNOLOGY

Hyperglycemia-Induced Reactive Oxygen Species Toxicity to Endothelial Cells Is Dependent on Paracrine Mediators

(2008) J. V. Busik et al.   DIABETES

In vivo imaging in mice reveals local cell dynamics and inflammation in obese adipose tissue

(2008) Satoshi Nishimura et al.   JOURNAL OF CLINICAL INVESTIGATION

Alterations in cell adhesion molecules and other biomarkers of cardiovascular disease in patients with metabolic syndrome

(2007) Leonardo Gómez Rosso et al.   ATHEROSCLEROSIS